Paris
France
31
2013-08-01
SANOFI from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:
USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS
#2 | 2013-07-25BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY
#3 | 2013-07-18Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
#4 | 2013-06-27Process for preparing aminobenzoylbenzofuran derivatives
#5 | 2013-06-27Process for preparing benzofuran derivatives substituted at position 5
#6 | 2013-06-27Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
#7 | 2013-06-136-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
#8 | 2013-05-30DERIVATIVES OF OXADIAZOLE AND PYRIDAZINE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
#9 | 2013-05-30Anticancer derivatives, preparation thereof and therapeutic use thereof
#10 | 2013-05-23Process for the preparation of dronedarone
#11 | 2013-05-16POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
#12 | 2013-05-16ANTITUMORAL COMBINATION COMPRISING OMBRABULIN, A TAXANE DERIVATIVE AND A PLATINUM DERIVATIVE
#13 | 2013-05-09Solid Pharmaceutical Compositions Containing Benzofuran Derivatives
#14 | 2013-05-02Process for the preparation of dronedarone
#15 | 2013-04-25METHODS FOR REDUCING RISK
#16 | 2013-04-18Method of synthesis of ferroquine by convergent reductive amination
#17 | 2013-04-113,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta
#18 | 2013-04-046-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
#19 | 2013-03-21Method for determining the stability of organic methyleneamines in the presence of semicarbazide-sensitive amine oxidase
#20 | 2013-03-14Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
#21 | 2013-03-14Substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
#22 | 2013-03-14Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
#23 | 2013-03-07Substituted N-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
#24 | 2013-03-07SUBSTITUTED N-PHENYL SPIROLACTAM BIPYRROLIDINES, PREPARATION AND THERAPEUTIC USE THEREOF
#25 | 2013-03-07Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
#26 | 2013-03-07Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
#27 | 2013-03-07Composition and Method for Treatment of Tumors
#28 | 2013-02-14Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
#29 | 2013-02-14Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
#30 | 2013-01-31Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#31 | 2013-01-24Process for preparing aminobenzofuran derivatives
55226 ⎘